Trial Comparing Glucantime Alone vs. with CO2 Laser for Cutaneous Leishmaniasis
A randomized controlled trial is underway to assess the efficacy of intralesional Glucantime alone versus in combination with fractional CO₂ laser therapy for cutaneous leishmaniasis.